Skip to content

Imax IMAX Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66 logo
Phillips 66PSX
$5.15B+246%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$8.48B-61.9%
3M logo
3MMMM
$3.73B-41.1%
eBay logo
eBayEBAY
$4.23B+1.9%
American Financial Group logo
American Financial GroupAFG
$1.35B+6.0%
Erie Indemnity Company logo
Erie Indemnity CompanyERIE
$268.62M+3.2%

Other financials

Income statement

See full
Revenue$81.4M-6.1%
Gross profit$45.8M-13.9%
Operating income$10.0M-40.5%
Net income$4.2M+81.6%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$146.0M+50.4%
Total debt$11.1M-6.7%
Total equity$335.5M+12.0%
Total assets$893.2M+5.3%

Cash flow

See full
Operating cash flow$4.0M-42.0%
CapEx$2.1M+29.6%
Free cash flow$1.9M-64.2%

Valuation

See full
Market cap$2.47B+46.9%
P/E67.3×+0.2×
P/S6.1×+1.4×

Profitability

See full
Gross margin59%+4.4pp
Operating margin19.1%+5.6pp
Net margin9.1%+2.1pp
FCF margin28.5%+6.3pp

Returns & leverage

See full
Return on equity11.6%+2.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Imax's cash and cash equivalents, end of period?
Imax (IMAX) reported cash and cash equivalents, end of period of $146M in Q1 2026.
How has Imax's cash and cash equivalents, end of period changed year-over-year?
Imax's cash and cash equivalents, end of period increased by 50.4% year-over-year, from $97.07M to $146M.
What is the long-term trend for Imax's cash and cash equivalents, end of period?
Over 4 years (2021 to 2025), Imax's cash and cash equivalents, end of period has grown at a -5.5% compound annual growth rate (CAGR), from $189.71M to $151.17M.